Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.25 USD | -0.79% | -15.54% | -5.30% |
05-09 | Nkarta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-26 | Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.30% | 440M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- NKTX Stock
- News Nkarta, Inc.
- Nkarta Says FDA Clears IND Application for Lupus Nephritis Treatment; Planning Cost Cuts to Extend Cash Runway